Perrigo Company plc (PRGO)
NYSE: PRGO · Real-Time Price · USD
28.04
-0.02 (-0.07%)
At close: Mar 31, 2025, 4:00 PM
27.46
-0.58 (-2.07%)
After-hours: Mar 31, 2025, 5:47 PM EDT
Perrigo Company Market Cap
Perrigo Company has a market cap or net worth of $3.83 billion as of March 31, 2025. Its market cap has decreased by -8.98% in one year.
Market Cap
3.83B
Enterprise Value
7.10B
1-Year Change
-8.98%
Ranking
Category
Stock Price
$28.04
Market Cap Chart
Since December 1, 1998, Perrigo Company's market cap has increased from $622.50M to $3.83B, an increase of 514.67%. That is a compound annual growth rate of 7.14%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Mar 28, 2025 | 3.83B | 9.16% |
Dec 31, 2024 | 3.51B | -19.56% |
Dec 29, 2023 | 4.36B | -5.00% |
Dec 30, 2022 | 4.59B | -11.80% |
Dec 31, 2021 | 5.20B | -14.75% |
Dec 31, 2020 | 6.10B | -13.19% |
Dec 31, 2019 | 7.03B | 33.57% |
Dec 31, 2018 | 5.26B | -57.12% |
Dec 29, 2017 | 12.28B | 2.87% |
Dec 30, 2016 | 11.93B | -43.67% |
Dec 31, 2015 | 21.18B | -5.39% |
Dec 31, 2014 | 22.39B | 54.74% |
Dec 31, 2013 | 14.47B | 48.17% |
Dec 31, 2012 | 9.77B | 7.71% |
Dec 30, 2011 | 9.07B | 55.24% |
Dec 31, 2010 | 5.84B | 60.58% |
Dec 31, 2009 | 3.64B | 22.02% |
Dec 31, 2008 | 2.98B | -8.90% |
Dec 31, 2007 | 3.27B | 104.21% |
Dec 29, 2006 | 1.60B | 15.06% |
Dec 30, 2005 | 1.39B | 13.24% |
Dec 31, 2004 | 1.23B | 11.97% |
Dec 31, 2003 | 1.10B | 30.33% |
Dec 31, 2002 | 842.80M | -3.10% |
Dec 31, 2001 | 869.80M | 42.87% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 738.61B |
UnitedHealth Group | 472.03B |
Johnson & Johnson | 394.52B |
AbbVie | 363.15B |
Novo Nordisk | 305.46B |
AstraZeneca | 229.16B |
Abbott Laboratories | 226.88B |
Merck & Co. | 225.40B |